Browse the evidence

Hypothalamic inflammation and endoplasmic reticulum stress are key drivers of leptin resistance, mediated by inflammatory cytokines like IL-6 and TNF-alpha induced by high-fat diets.

High-fat diets trigger inflammation in fat and liver tissue, which releases cytokines (IL-6, TNF-alpha) that disrupt leptin signaling in the brain. Managing inflammation through diet quality (reducing high-fat intake) may help restore leptin sensitivity.

GLP-1 receptor agonists that reduce receptor internalization and beta-arrestin recruitment produce greater sustained insulin secretion and glycemic benefits without increasing nausea side effects compared to standard FDA-approved GLP-1 mimetics.

Current GLP-1 drugs often cause nausea because they trigger strong receptor internalization and beta-arrestin signaling. Research suggests that 'biased' agonists, which keep the receptor on the cell surface longer and avoid beta-arrestin, may provide better blood sugar control with fewer stomach side effects. While these specific compounds are not yet FDA-approved, the mechanism highlights why tolerability varies between different GLP-1 medications.

Metformin use significantly alters gut microbiota composition and contributes to its beneficial effects on glucose homeostasis, acting as a strong confounder in metagenomic studies of T2DM.

If you take Metformin for diabetes, your gut bacteria are likely different from non-users. This is a known effect of the drug and may contribute to its benefits. Do not stop taking prescribed medication to 'fix' your microbiota naturally without consulting your doctor.

Low socioeconomic status (SES) is associated with accelerated epigenetic aging, specifically an increase in biological age of approximately 1 year compared to high SES, independent of major lifestyle risk factors.

Social environment impacts biological aging. While you cannot change your past, improving your social and economic conditions, especially in early life, may help slow down biological aging processes. Focus on reducing chronic stress and building supportive social networks as these are key components of socioeconomic well-being.

Aging adipose tissue undergoes early structural and functional decline, characterized by visceral fat redistribution, loss of brown/beige fat, and accumulation of senescent cells, which drives systemic metabolic dysfunction and accelerates aging.

Your fat cells are not just storage; they are active organs that signal your body's health status. As you age, these signals can become harmful, leading to inflammation and metabolic issues. Maintaining healthy adipose tissue through balanced nutrition and activity is crucial for slowing down age-related decline.

Aging is associated with a decline in skeletal muscle mitochondrial capacity, exercise efficiency, and insulin sensitivity, even when habitual physical activity levels are comparable to young adults.

Aging naturally reduces muscle mitochondrial capacity and insulin sensitivity, even if you stay active. This decline contributes to reduced exercise efficiency and physical function, highlighting the importance of targeted exercise training to mitigate these age-related changes.

Intermittent administration of the senolytic drug combination dasatinib and quercetin (D&Q) reduces senescence and inflammation in adipose tissue, leading to improved systemic metabolic function (fasting glucose, glucose tolerance, and lipid profiles) in old age.

For older adults, intermittent treatment with dasatinib and quercetin may improve metabolic health by clearing senescent cells from fat tissue, reducing inflammation, and improving glucose tolerance. This suggests that targeting cellular aging could be a viable strategy for managing age-related metabolic decline.

Fructose consumption promotes disease progression from simple steatosis to nonalcoholic steatohepatitis (NASH) by inducing oxidative stress, endoplasmic reticulum (ER) stress, and inflammation via mechanisms including uric acid production and methylglyoxal accumulation.

If you have fatty liver, reducing fructose is crucial not just for fat loss but to stop the inflammation and stress that turn simple fat accumulation into serious liver disease (NASH).

Chronic systemic inflammation drives skeletal muscle atrophy by directly activating pro-catabolic signaling pathways (NF-κB, JAK/STAT, p38MAPK) that increase protein degradation via UPS/ALP and inhibit protein synthesis via IGF-1/Akt/mTOR suppression.

If you are experiencing muscle loss alongside a chronic inflammatory condition (like autoimmune disease, diabetes, or chronic infection), standard resistance training and high protein intake may be insufficient on their own. Medical management of the underlying inflammation is critical to stop the biological signals that actively break down muscle tissue.

Inflammation indirectly causes muscle atrophy by dysregulating the Hypothalamic-Pituitary-Adrenal (HPA) axis, leading to excessive glucocorticoid release, which further inhibits muscle protein synthesis and promotes proteolysis.

Managing stress and underlying inflammation is crucial because chronic stress and inflammation can trigger hormonal responses (cortisol) that actively break down muscle. Medical interventions that stabilize the HPA axis or reduce inflammatory cytokines may help preserve muscle mass.

Myostatin (MSTN) levels are increased by inflammatory factors (TNF-α, IL-6) and act as a negative regulator of muscle mass by activating the Smad2/3 pathway, which upregulates E3 ubiquitin ligases (MuRF1, Atrogin-1) and inhibits satellite cell recruitment.

High levels of inflammatory cytokines can increase Myostatin, a protein that naturally limits muscle growth. In chronic disease, this system is overactive, contributing to muscle loss. Therapies targeting Myostatin or its receptors are being investigated to counteract this loss.

Higher body mass index (BMI > 25 kg/m²) is associated with a protective effect against hip fracture burden, reducing DALYs by up to 24.1% for BMI > 35 kg/m² compared to a BMI of 21.5–25 kg/m².

This study suggests that higher body weight (BMI > 25) may protect against hip fractures, likely due to mechanical cushioning. However, the authors explicitly state that recommending weight gain is inappropriate due to the association with other morbidities. Focus on maintaining a healthy weight through balanced nutrition and activity rather than targeting weight loss specifically for bone health.

Mechanical unloading (disuse) induces skeletal muscle atrophy primarily through a dual mechanism: suppression of the IGF-1-Akt-mTOR protein synthesis pathway and upregulation of the ubiquitin-proteasome system (specifically MuRF1/MAFbx E3 ligases) driven by FOXO transcription factors.

If you are experiencing forced inactivity (like casting or bed rest), your muscles will shrink due to suppressed growth signals (mTOR) and increased breakdown signals (FOXO/MuRF1). While you cannot fully stop this, engaging in any available resistance exercise (even isometric) or ensuring adequate protein intake may help mitigate the rate of loss by keeping these pathways partially active.

Oxidative stress (ROS overproduction) and Calcium (Ca2+) overload are major triggers that exacerbate disuse-induced muscle atrophy by promoting protein breakdown and inhibiting synthesis.

Managing oxidative stress and calcium handling may help protect muscle during periods of inactivity. Antioxidants and strategies to maintain muscle membrane integrity might be beneficial, though the paper notes these are 'potential countermeasures' requiring more research.

Zinc deficiency is a widespread public health problem in low- and middle-income countries, with prevalence often exceeding 20% in various physiological groups, as measured by plasma zinc concentration.

In many low- and middle-income countries, zinc deficiency is a major public health issue affecting over 20% of the population in various groups. Public health efforts should prioritize screening and intervention, especially for women and children, using plasma zinc concentration as a key indicator.

Mitochondrial dysfunction acts as a primary driver of skeletal muscle atrophy by triggering catabolic signaling pathways that promote the expression of muscle atrophy genes and increasing oxidative stress.

To support muscle mass, prioritize activities that improve mitochondrial health, such as regular aerobic and resistance exercise. These interventions help regulate mitochondrial function and may prevent or treat muscle atrophy, especially in aging or diseased states.

GLP-1 receptor agonists (GLP-1RAs) exert anti-inflammatory effects by suppressing pro-inflammatory cytokine production (TNF-α, IL-6, IL-1β) and inhibiting the NF-κB pathway, independent of glycemic control.

GLP-1 medications like semaglutide and liraglutide do more than just lower blood sugar; they actively reduce systemic inflammation by blocking key inflammatory pathways (NF-κB) and lowering pro-inflammatory cytokines. This benefit exists regardless of whether your blood sugar improves, suggesting these drugs may help with inflammatory conditions beyond diabetes.

Augmentation of NAD+ levels via precursors (NR or NMN) restores mitophagy and extends lifespan in Werner syndrome models.

For individuals with genetic conditions affecting DNA repair (like Werner Syndrome) or those seeking to mitigate age-related metabolic decline, supplementing with NAD+ precursors like Nicotinamide Riboside (NR) or Nicotinamide Mononucleotide (NMN) can restore cellular energy metabolism and extend healthspan. This is achieved by boosting NAD+ levels, which activates mitophagy (clearing of damaged mitochondria) via the DCT-1 and ULK-1 pathways, thereby delaying aging phenotypes.

Dietary capsaicin supplementation prevents high-fat diet-induced obesity and chronic low-grade inflammation by modulating gut microbiota to increase butyrate-producing bacteria and decrease lipopolysaccharide-producing bacteria, thereby strengthening the gut barrier and reducing metabolic endotoxemia.

Incorporating capsaicin (found in chili peppers) into a high-fat diet can help mitigate weight gain and inflammation by improving gut health. The mechanism involves increasing beneficial bacteria that produce butyrate and reducing harmful bacteria that trigger inflammation. While this is proven in mice, it suggests that chili consumption may be a useful dietary strategy to support metabolic health, particularly when consuming higher-fat meals.

Obesity induces low-grade chronic inflammation in white adipose tissue (WAT) via adipocyte death (apoptosis/necroptosis), which recruits pro-inflammatory macrophages (forming crown-like structures) and triggers systemic insulin resistance and metabolic syndrome.

Obesity is not just about storing fat; it is an active inflammatory state. Excess fat, especially visceral fat, leads to adipocyte death, which triggers an immune response (inflammation) that blocks insulin signaling. To improve metabolic health, strategies must address this underlying inflammation, not just caloric intake, by supporting adipose tissue health and reducing cytokine-driven resistance.

TNF and NF-κB signaling pathways directly inhibit insulin signaling by phosphorylating IRS-1, thereby causing insulin resistance; neutralizing TNF or inhibiting IKKβ improves glucose homeostasis.

Chronic inflammation in fat tissue directly blocks insulin's ability to work by interfering with key signaling proteins (IRS-1). Reducing this inflammation, whether through weight loss, exercise, or potentially anti-inflammatory strategies, can restore insulin sensitivity.

Slow-wave sleep (N3 stage) is the primary driver of glymphatic clearance, facilitating the removal of neurotoxic waste products like amyloid-beta and tau from the brain.

Prioritize getting enough slow-wave sleep (deep sleep) to allow your brain to clear out metabolic waste like amyloid-beta. This happens naturally during the N3 stage of sleep. Protecting this sleep phase is a critical preventative measure against neurodegenerative diseases like Alzheimer's.

Obesity-induced adipose tissue fibrosis, driven by unresolved inflammation and hypoxia, restricts adipose expandability and contributes to insulin resistance and resistance to weight loss.

Focus on preventing fat tissue damage (fibrosis) rather than just losing weight. Strategies that reduce inflammation and improve vascularization in fat tissue may be more metabolically beneficial than weight loss alone, especially in severe obesity.

Promoting angiogenesis (healthy vascularization) in adipose tissue reduces inflammation and fibrosis, whereas suboptimal vascularization leads to hypoxia and insulin resistance.

Maintaining good blood flow to fat tissue through exercise and healthy lifestyle may help prevent the stiffening (fibrosis) of fat tissue, which is linked to insulin resistance.